\documentclass[aspectratio=169]{beamer}
%\documentclass[handout]{beamer}

% language settings
%\usepackage{fontspec, polyglossia}
%\setdefaultlanguage{magyar}

% common packages
\usepackage{amsmath, multimedia, hyperref, color, multirow}
%\usepackage{graphicx}
\usepackage{xcolor}
\definecolor{BlueGreen}{cmyk}{0.85,0,0.33,0}
\usepackage{url}

% TikZ
\usepackage{tikz}
%\usetikzlibrary{arrows.meta, decorations.pathmorphing, decorations.pathreplacing, shapes.geometric,mindmap}
%\usetikzlibrary{shapes.geometric,fadings,bayesnet}

% beamer styles
\mode<presentation>{
%\usetheme{Madrid}
\usetheme{default}
%\usetheme{Antibes}
%\usecolortheme{beaver}
\usecolortheme{default}
%\usecolortheme{dove}
%\usefonttheme{structureitalicserif}
\setbeamercovered{transparent}
}
\setbeamertemplate{blocks}[rounded][shadow=true]
\AtBeginSubsection[]{
  \begin{frame}<beamer>{Contents}
    \tableofcontents[currentsection,currentsubsection]
  \end{frame}
}
%\useoutertheme[]{tree}

% title, etc
\title{Bayesian analysis of cell based assays}
\subtitle{}
\author{Attila Jones}
\date{}

\begin{document}

\titlepage

\begin{frame}{Motivation}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\includegraphics[width=1.0\columnwidth]{../../../notebooks/2022-09-21-cell-based-assays/named-figure/heatmap-agg-assay.pdf}
\end{column}

\begin{column}{0.5\textwidth}
  \begin{itemize}
    \item effect size?
  \begin{itemize}
    \item assumption:\\neuroprotectivity $\propto -\log p$-value
  \end{itemize}
    \item dose-dependence?
  \begin{itemize}
    \item Dunnett's test: $c_1 \overset{H_0^{(c_1)}}{\leftrightarrow} \mathrm{ctr} \overset{H_0^{(c_2)}}{\leftrightarrow} c_2$
  \end{itemize}
    \item aggregation?
  \end{itemize}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Example: Arundine/IL26, TNF$\alpha$ assay in iPSC-derived microglia }
\begin{columns}[t]
\begin{column}{0.4\textwidth}

\includegraphics[width=1.0\columnwidth]{figures/TI26_TNF.pdf}
%\includegraphics[width=1.0\columnwidth]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/data-TI26-TNF.pdf}
\end{column}

\begin{column}{0.6\textwidth}

\begin{tabular}{rcc}
  Test & Comparison & $p\text{-val}|H_0$  \\
  \hline
  Tina et al & & \\
  \hline
  ANOVA & multiple & 0.14 \\
  Bartlett's & multiple & $<10^{-4}$ \\
  Dunnett's & $\mathrm{LC} \leftrightarrow c_1$ & 0.39 \\
  Dunnett's & $\mathrm{LC} \leftrightarrow c_2$ & 0.92 \\
  Dunnett's & $\mathrm{LC} \leftrightarrow c_3$ & 0.93 \\
  \hline
  \alert{New: CTNS} & & \\
  \hline
  Spearman's & correlation & $0.0051$ \\
  Bayesian  & regression & $P(H_1) = 0.999$ \\
  \hline
  \end{tabular}
  %$P(H_1|\mathrm{data})$
\end{column}
\end{columns}
\end{frame}


\begin{frame}{Frequentist and Bayesian statistics}
\begin{center}
\includegraphics[width=0.8\textwidth]{~/figures/Fisher-Bayes-cartoon.jpeg}

  \tiny{\url{https://agostontorok.github.io/2017/03/26/bayes_vs_frequentist/}}
\end{center}
\end{frame}

\begin{frame}{Bayesian inference: }{Example: Arundine/IL26, TNF$\alpha$ assay in iPSC-derived microglia }
\begin{columns}[b]
\begin{column}{0.45\textwidth}

\includegraphics[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/sigmoid-2-draw_y0_y1.pdf}
\end{column}
\begin{column}{0.45\textwidth}

\includegraphics[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/prior-posterior-density-sigmoid-2.pdf}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{sigmoid 2: a Bayesian regression model}
\begin{columns}%[t]
\begin{column}{0.5\textwidth}

\includegraphics<1>[width=0.8\columnwidth]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/sigmoid-2.png}
\includegraphics<2>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/sigmoid-2-draw_y0_y1.pdf}
\end{column}

\begin{column}{0.5\textwidth}

  \begin{tabular}{cc}
     Data var. & Interpretation \\
     \hline
     $x$ & drug eff. conc. \\
     $Y \sim \mathcal{N}(\mu, \sigma \mu)$ & activity (bioassay) \\
  \end{tabular}

\begin{eqnarray*}
\mu &=& \left| y_1 + \frac{y_0 - y_1}{(1 + \exp(k * (x - \mathrm{EC}_{50})} \right| \\
\mathrm{FC}_y &=& \frac{y_1}{y_0} \\
%\mu &=& \left| y_0 \mathrm{FC}_y + \frac{y_0 (1 - \mathrm{FC}_y)}{(1 + \exp(k * (x - \mathrm{EC}_{50})} \right|
\end{eqnarray*}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Fitting sigmoid 2: Markov chain Monte Carlo (MCMC)}{Example: Arundine/IL26, TNF$\alpha$ assay in iPSC-derived microglia }
\begin{center}
\includegraphics[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/mcmc-trace-sigmoid-2.pdf}
\end{center}
\end{frame}

\begin{frame}{Model selection I.}{Fit evaluated by objective EPLD criterion}%{A good fit is not all.}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\begin{tabular}{rl}
Model & Error distribution \\
\hline
linear 1  & $Y \sim \mathcal{N}(\mu, \sigma)$ \\
sigmoid 1  & $Y \sim \mathcal{N}(\mu, \sigma)$ \\
sigmoid 2  & $Y \sim \mathcal{N}(\mu, \sigma \mu)$ \\
sigmoid 3  & $Y \sim \Gamma(\alpha \mu, \beta)$ \\
sigmoid 4  & $Y \sim \Gamma(\alpha, \frac{\beta}{\mu})$ \\
\end{tabular}
\end{column}

\begin{column}{0.5\textwidth}

\includegraphics<1>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/model-comparison.pdf}
\includegraphics<2>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/posterior-predictive-sigmoid.png}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Model selection II.}{Fit evaluated by a subjective criterion}%{A good fit is not all.}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\includegraphics<1>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/prior-posterior-curves-sigmoid-2.pdf}
\includegraphics<2>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/prior-posterior-density-sigmoid-2.pdf}
\end{column}

\begin{column}{0.5\textwidth}

\includegraphics<1>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/prior-posterior-curves-sigmoid-4.pdf}
\includegraphics<2>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/prior-posterior-density-sigmoid-4.pdf}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Preliminary results: TI1 (Amiloride), TI26 (Arundine, DIM)}
\begin{columns}[t]
\begin{column}{0.5\textwidth}

\includegraphics<1>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/P_H1-barchart.pdf}
\includegraphics<2>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/P_H1-heatmap.pdf}
\end{column}

\begin{column}{0.5\textwidth}

\includegraphics<1>[scale=0.5]{../../../notebooks/2023-09-13-cell-based-assays-bayes/named-figure/data-posterior-curve-TI26-MTT.pdf}
\includegraphics<2>[width=1.0\columnwidth]{../../../notebooks/2022-09-21-cell-based-assays/named-figure/heatmap-agg-assay.pdf}
\end{column}
\end{columns}
\end{frame}


\end{document}

\begin{columns}[t]
\begin{column}{0.5\textwidth}
\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
